NO137387C - Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning - Google Patents
Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkningInfo
- Publication number
- NO137387C NO137387C NO3261/73A NO326173A NO137387C NO 137387 C NO137387 C NO 137387C NO 3261/73 A NO3261/73 A NO 3261/73A NO 326173 A NO326173 A NO 326173A NO 137387 C NO137387 C NO 137387C
- Authority
- NO
- Norway
- Prior art keywords
- methyltiopyrimidines
- preparation
- therapeutic effect
- analogical procedure
- analogical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7324875A FR2244520B1 (no) | 1973-07-06 | 1973-07-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO326173L NO326173L (no) | 1975-02-03 |
| NO137387B NO137387B (no) | 1977-11-14 |
| NO137387C true NO137387C (no) | 1978-02-22 |
Family
ID=9122192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO3261/73A NO137387C (no) | 1973-07-06 | 1973-08-16 | Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3968214A (no) |
| JP (1) | JPS5025576A (no) |
| BE (1) | BE803804A (no) |
| CH (1) | CH581120A5 (no) |
| DE (1) | DE2342881A1 (no) |
| ES (1) | ES418114A1 (no) |
| FR (1) | FR2244520B1 (no) |
| GB (1) | GB1450211A (no) |
| LU (1) | LU68264A1 (no) |
| NL (1) | NL7312324A (no) |
| NO (1) | NO137387C (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2417507A2 (fr) * | 1977-07-28 | 1979-09-14 | Ugine Kuhlmann | Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides |
| US4560402A (en) * | 1979-08-15 | 1985-12-24 | Ciba Geigy Corporation | 2,4-Diamo-5-(alkylsulfinyl) or alkylsulphonyl)-6-halopyrimidines |
| FR2503162A1 (fr) * | 1981-04-07 | 1982-10-08 | Pharmindustrie | Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments |
| DE3417264A1 (de) * | 1984-05-10 | 1985-11-14 | Bayer Ag, 5090 Leverkusen | Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine |
| US5002949A (en) * | 1990-05-01 | 1991-03-26 | American Home Products Corporation | 5-substituted-6-aminopyrimidine derivatives |
| US7205320B2 (en) * | 2001-01-22 | 2007-04-17 | Memory Pharmaceuticals Corp. | Phosphodiesterase 4 inhibitors |
| MXPA05000825A (es) * | 2002-07-19 | 2005-08-29 | Memory Pharm Corp | Compuestos de 6-amino-1h-indazol y 4-aminobenzofurano como inhibidores de fosfodiesterasa 4. |
| JP4666256B2 (ja) | 2002-12-10 | 2011-04-06 | 小野薬品工業株式会社 | 含窒素複素環化合物およびその医薬用途 |
| CA2611562A1 (en) * | 2005-06-10 | 2006-12-21 | Memory Pharmaceuticals Corporation | Trisubstituted amines as phosphodiesterase 4 inhibitors |
| CA2653777A1 (en) | 2006-06-15 | 2007-12-21 | Boehringer Ingelheim International Gmbh | 2-anilino-4-(heterocyclic)amino-pyrimidines |
| CN101506176A (zh) | 2006-06-15 | 2009-08-12 | 贝林格尔.英格海姆国际有限公司 | 2-苯胺基-4-氨基亚烷基氨基嘧啶 |
| WO2010003084A2 (en) * | 2008-07-02 | 2010-01-07 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3817998A (en) * | 1971-10-28 | 1974-06-18 | Sandoz Ag | 2-amino and substituted amino-4, 6-diamino-5-pyrimidinesulfonamides |
-
1973
- 1973-07-06 FR FR7324875A patent/FR2244520B1/fr not_active Expired
- 1973-08-16 NO NO3261/73A patent/NO137387C/no not_active IP Right Cessation
- 1973-08-20 LU LU68264A patent/LU68264A1/xx unknown
- 1973-08-20 BE BE134752A patent/BE803804A/xx unknown
- 1973-08-22 ES ES418114A patent/ES418114A1/es not_active Expired
- 1973-08-23 CH CH1213573A patent/CH581120A5/xx not_active IP Right Cessation
- 1973-08-24 DE DE19732342881 patent/DE2342881A1/de not_active Ceased
- 1973-09-06 JP JP48100729A patent/JPS5025576A/ja active Pending
- 1973-09-07 NL NL7312324A patent/NL7312324A/xx active Search and Examination
- 1973-09-12 GB GB4286773A patent/GB1450211A/en not_active Expired
- 1973-10-12 US US05/406,129 patent/US3968214A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES418114A1 (es) | 1976-03-16 |
| FR2244520A1 (no) | 1975-04-18 |
| FR2244520B1 (no) | 1977-02-04 |
| DE2342881A1 (de) | 1975-01-30 |
| LU68264A1 (no) | 1973-10-24 |
| GB1450211A (en) | 1976-09-22 |
| NL7312324A (nl) | 1975-01-08 |
| US3968214A (en) | 1976-07-06 |
| NO137387B (no) | 1977-11-14 |
| JPS5025576A (no) | 1975-03-18 |
| BE803804A (fr) | 1974-02-20 |
| CH581120A5 (no) | 1976-10-29 |
| NO326173L (no) | 1975-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO145273C (no) | N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere | |
| SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
| NO138374C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater | |
| SE7710599L (sv) | Forfarande for framstellning av bensisoxazoler | |
| SE406197B (sv) | Analogiforfarande for framstellning av 4-aminokinazolinderivat | |
| FI55846C (fi) | Foerfarande foer framstaellning av 8-azapurin-5-onderivat med terapeutisk anvaendning | |
| NO740606L (no) | Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser. | |
| NO137387C (no) | Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| SE417601B (sv) | Forfarande for framstellning av amidinokarbamider | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| SE399263B (sv) | Analogiforfarande for framstellning av triazaspirodekaner med terapeutisk verkan | |
| SE409716B (sv) | Analogiforfarande for framstellning av 11beta-alkyl-delta4-estrener | |
| NO843825L (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin | |
| NO136795C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner | |
| SE7607717L (sv) | Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid | |
| SE399069B (sv) | Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat | |
| SE426582B (sv) | Forfarande for framstellning av foreningar med kolesterolsenkande effekt | |
| NO138561C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater | |
| SE410596B (sv) | Analogiforfarande for framstellning av bensoyl-fenylalanyl-tyrosinderivat med terapeutisk verkan | |
| NO137205C (no) | Analogifremgangsm}te for fremstilling av piperazinpyrimidiner med terapeutisk virkning. | |
| NO740607L (no) | Analogifremgangsmåte til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser. | |
| NO137752C (no) | Analogifremgangsmaater til fremstilling av forbindelser med antiarrytmisk virkning | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| NO140104C (no) | Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |